On August 11, Altria declined 3.03% in regular trading, trading at $66.3/share, with turnover of $291 million. The tobacco sector faced broad selling pressure during the session.

The decline came as the tobacco sector collectively weakened, with British American Tobacco falling 3.83%, Universal dropping 7.08%, and Philip Morris declining 1.56%. The sector pressure was compounded by lingering concerns following Altria's Q2 earnings report, which showed adjusted EPS of $1.48, missing the analyst consensus estimate of $1.50. Revenue came in at $6.11 billion, essentially flat year-over-year. The company's oral nicotine pouch business saw volume declines, partially offsetting cigarette gains. Altria narrowed its full-year adjusted EPS guidance to $5.61-$5.72, with management citing expectations that second-half tobacco import/export activity would contribute greater earnings. However, executives acknowledged that persistent economic pressure on consumers continues to reshape the cigarette industry landscape, weighing on the company's profitability outlook.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)